|
Sheldon A. Schaffer Ph.D. joined Aastrom in December 2006 as Vice President Corporate Development & Intellectual Property a newly created position. Dr. Schaffer has more than 30 years of experience in pharmaceutical and medical diagnostics industries at both large corporations and entrepreneurial start-up companies. During his career he has been responsible for the development of U.S. and international businesses in- and out-licensing of technology intellectual property management and clinical and pre-clinical drug development and drug discovery management. Most recently Dr. Schaffer has provided business development consulting services to the pharmaceutical industry. Prior to this he served as President and CEO of Inveresk Research N.A. He served as Vice President Pharmaceutical Development at DepoTech Corporation and as Vice President of Pharmaceutical Development and then as Vice President of Business Development at Cholestech Corporation a publicly traded medical products company. Previously Dr. Schaffer served as Director Inflammation/Atherosclerosis Research at Ciba-Geigy Corporation a pharmaceutical company and held senior scientific positions at the Medical Research Division of American Cyanamid Co. a pharmaceutical company. Dr. Schaffer received his B.S. in chemistry from the University of California Berkeley and a Ph.D. in chemistry from the University of Illinois and served as a postdoctoral and teaching fellow at Harvard Medical School. | 